<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html40/strict.dtd"><!-- Created from PDF via Acrobat SaveAsXML --><!-- Mapping table version: 28-February-2003 --><HTML><HEAD><META http-equiv="Content-Type" content="text/html; charset=UTF-8"><STYLE type="text/css">DIV[class="Part"] { text-align:left; margin-bottom:0px; margin-top:0px; margin-right:0px; text-indent:0px; direction:ltr}H2 { text-align:center; margin-bottom:56px; margin-top:0px; margin-right:0px; text-indent:0px; direction:ltr; line-height:25px}SPAN { font-family:'Times New Roman PS','Times New Roman PS',serif; font-size:16.3pt; font-style:normal; font-weight:bold}IMG { text-align:center; vertical-align:top; margin-bottom:48px; margin-top:0px; margin-right:0px; margin-left:0px; direction:ltr}DIV[class="Sect"] { text-align:left; margin-bottom:0px; margin-top:0px; margin-right:0px; text-indent:0px; direction:ltr}H3 { text-align:center; margin-bottom:49px; margin-top:0px; margin-right:0px; text-indent:0px; direction:ltr; line-height:25px}P { text-align:center; margin-bottom:49px; margin-top:0px; margin-right:0px; text-indent:0px; direction:ltr; line-height:25px}H4 { text-align:left; margin-bottom:19px; margin-top:0px; margin-right:0px; text-indent:0px; direction:ltr; line-height:18px}OL { list-style-type:decimal; text-align:left; margin-bottom:0px; margin-top:0px; margin-right:0px; text-indent:0px; direction:ltr}LI { list-style-type:decimal; text-align:left; margin-bottom:19px; margin-top:0px; margin-right:31px; text-indent:0px; direction:ltr; line-height:19px}DT { text-align:left; margin-bottom:19px; margin-top:0px; margin-right:31px; text-indent:0px; direction:ltr}DD { text-align:left; margin-bottom:19px; margin-top:0px; margin-right:31px; text-indent:0px; direction:ltr}</STYLE><META name="dc.date" content="2007-04-27T12:02:14-04:00" ><META name="dc.date.modified" content="2007-04-27T12:02:14-04:00" ><META name="generator" content="Adobe Acrobat Exchange-Pro 8.0" ></HEAD><BODY bgcolor=white text=black link=blue vlink=purple alink=fushia ><DIV class="Part"><H2><SPAN style="color:#000000">ADVANCES IN UNDERSTANDING MECHANISMS AN</SPAN><SPAN style="color:#000000">D 
</SPAN><SPAN style="color:#000000">TREATMENT OF INFANTILE FORMS OF NYSTAGMU</SPAN><SPAN style="color:#000000">S 
</SPAN></H2><IMG width=155 height=217 style="display:block; float:none" src="images/conference program_img_0.jpg"><DIV class="Sect"><H3><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">A Conference to Honor Louis F. Dell’Osso, Ph.D. an</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">d 
</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">Celebrate the Opening of th</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">e 
</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">Daroff</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">Dell’Osso Ocular Motility Laborator</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">y 
</SPAN></H3><P><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">May 3</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">4, 200</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:15.8pt; font-weight:normal; color:#000000">7 
</SPAN></P><DIV class="Sect"><H3 style="margin-bottom:123px; line-height:23px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:14.8pt; font-weight:normal; color:#000000">Louis Stokes C</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:14.8pt; font-weight:normal; color:#000000">levelan</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:14.8pt; font-weight:normal; color:#000000">d 
</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:14.8pt; font-weight:normal; color:#000000">Department of Veterans Affairs Medical Cente</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:14.8pt; font-weight:normal; color:#000000">r 
</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:14.8pt; font-weight:normal; color:#000000">&amp; Case Western Reserve University, Cleveland Ohi</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:14.8pt; font-weight:normal; color:#000000">o 
</SPAN></H3></DIV></DIV><DIV class="Sect"><H3 style="margin-bottom:0px"><SPAN style="font-size:15.8pt; font-style:italic; font-weight:normal; color:#000000">Supported from a Grant fro</SPAN><SPAN style="font-size:15.8pt; font-style:italic; font-weight:normal; color:#000000">m 
</SPAN><SPAN style="font-size:15.8pt; font-style:italic; font-weight:normal; color:#000000">the Garson Fund of the Mount Sinai Fund of Cleveland, Ohi</SPAN><SPAN style="font-size:15.8pt; font-style:italic; font-weight:normal; color:#000000">o 
</SPAN></H3><DIV class="Sect"><H4><SPAN style="font-size:12pt; color:#000000">Thursday May 3rd, 2007 </SPAN><SPAN style="font-size:12pt; color:#000000">BRB Research Building </SPAN><SPAN style="font-size:12pt; color:#000000">– </SPAN><SPAN style="font-size:12pt; color:#000000">First Flo</SPAN><SPAN style="font-size:12pt; color:#000000">or Lecture Theater </SPAN></H4><P style="text-align:justify; margin-bottom:19px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">8:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Opening Remarks </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">– </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">John </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Leigh and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Michael </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Devereaux </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:211px; line-height:19px"><SPAN style="font-size:12pt; color:#000000">Session 1: Basic Concepts of </SPAN><SPAN style="font-size:12pt; color:#000000">Stable Vision </SPAN><SPAN style="font-size:12pt; color:#000000">and Gaze </SPAN><SPAN style="font-size:12pt; color:#000000">Chair: Robert B. Daroff </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:60px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">8:45 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Afferent and efferent contributions to knowledge of eye position </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Martin J. Steinbach, Toronto, Canada </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-right:60px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">9:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Perceptual influences of the extra</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">retinal signals for normal eye </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">movement and infantile nystagmus </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Harold E. Bedell</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Houston</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, TX </SPAN></P><P style="text-align:justify; margin-bottom:19px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">10:15 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">AM Coffee Break </SPAN></P><P style="text-align:left; margin-bottom:19px; margin-right:262px; margin-left:96px; text-indent:-95px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">10:45 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Perception with unstable vision </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Richard Abadi, Manchester, UK </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-right:7px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">11:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Internal and external influences on foveation and perception in infantile </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">nystagmus syndrome </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Larry A. Abel, Melbourne, Australia. </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:23px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">12:15 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Perceptual Fading during Voluntary and Involun</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">tary Eye Movements </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">F</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">rank </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A. Proudlock</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Leicester, U.K. </SPAN></P><P style="text-align:justify; margin-bottom:19px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">12:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">PM Lunch in BRB Lobby </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:108px; line-height:19px"><SPAN style="font-size:12pt; color:#000000">Session 2: </SPAN><SPAN style="font-size:12pt; color:#000000">New </SPAN><SPAN style="font-size:12pt; color:#000000">Models </SPAN><SPAN style="font-size:12pt; color:#000000">and Techniques for </SPAN><SPAN style="font-size:12pt; color:#000000">Studying </SPAN><SPAN style="font-size:12pt; color:#000000">Gaze Stability </SPAN><SPAN style="font-size:12pt; color:#000000">Chair: Louis F. Dell’Osso </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:105px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">1:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Alternating Saccades in a Primate Mo</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">dels of Strabismus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Vallabh Das, Atlanta</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, GA </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:113px; margin-left:96px; text-indent:-95px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">2:15 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Effects of cerebellar lesions in monkey on gaze stability </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Mark Walker, Baltimore</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, MD </SPAN></P><P style="text-align:justify; margin-bottom:19px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">3:00 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">PM Tea Break </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">3:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Development of visual stabilization devices with potent</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">ial applications to </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">congenital nystagmus </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Igor Kofman and John Stahl</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, Cleveland, OH </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">4:15 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Pupil abnormality of the near response in children with the “information </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">technology” syndrome </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Akio Tabuchi, Kawasaki, Japan </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:80px; text-indent:-79px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">4:45 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Adjourn; Walk back to Glidden House </SPAN></P><P style="text-align:justify; margin-bottom:56px; margin-left:80px; text-indent:-79px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">7:00 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Special Dinner (Coaches will collect guests at 6:30 pm from Glidden House) </SPAN></P><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; color:#000000">Friday May 4th, 2007 </SPAN><SPAN style="font-size:12pt; color:#000000">BRB Research Building </SPAN><SPAN style="font-size:12pt; color:#000000">– </SPAN><SPAN style="font-size:12pt; color:#000000">First Floor Lecture Theater </SPAN></P></DIV><DIV class="Sect"><H4 style="text-align:justify; margin-right:211px; line-height:19px"><SPAN style="font-size:12pt; color:#000000">Session 3: New Therapies for Congenital Nystagm</SPAN><SPAN style="font-size:12pt; color:#000000">us </SPAN><SPAN style="font-size:12pt; color:#000000">Chair: Michael Devereaux </SPAN></H4><P style="text-align:justify; margin-bottom:19px; margin-right:75px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">8:45 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Infantile nystagmus: Genetics and pharmacological treatment </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Irene Gottlob, Leicester, UK </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:98px; margin-left:96px; text-indent:-95px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">9:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">New treatments for infantile and other forms of nystagmus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Louis Dell’O</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">sso, Cleveland, OH </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-right:7px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">10:15 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Visual and Ocular Motor System Changes After Surgical Intervention in </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Infantile Nystagmus Syndrome </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Richard W. Hertle, Pittsburgh</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, PA </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:135px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">10:45 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Surgical treatments for acquired forms </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">of nystagmus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Robert Tomsak, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Cleveland, OH </SPAN></P><P style="text-align:left; margin-bottom:19px; margin-right:47px; margin-left:80px; text-indent:-79px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">11:15 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Walk to Louis Stokes Veterans Affairs Medical Center </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Tour of Daroff</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Dell’Osso Laboratory and Poster Session with Lunch </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:80px; text-indent:-79px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">1:15 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Return to BRB Building </SPAN></P><P style="text-align:justify; margin-bottom:19px; line-height:19px"><SPAN style="font-size:12pt; color:#000000">BRB Research Buildi</SPAN><SPAN style="font-size:12pt; color:#000000">ng </SPAN><SPAN style="font-size:12pt; color:#000000">– </SPAN><SPAN style="font-size:12pt; color:#000000">First Floor Lecture Theater </SPAN></P></DIV><DIV class="Sect"><H4 style="text-align:justify; margin-right:125px; line-height:18px"><SPAN style="font-size:12pt; color:#000000">Session 4: Open Papers from Laboratory Alumni and Colleagues </SPAN><SPAN style="font-size:12pt; color:#000000">Chair: John Leigh </SPAN></H4><P style="text-align:justify; margin-bottom:0px; margin-right:32px; margin-left:96px; text-indent:-95px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">1:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Effect of eye exercise on clinical outcome of non</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">compressive ocular </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">motor nerve palsy </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Anuchit Poonyathalang, Bangkok, Thailand </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">1:45 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">PM </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Expanding the Original Behavioral Infantile Nystagmus Syndrome Model </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">to Jerk Waveforms and Gaze</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">angle Variations </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Zhong Wang, Cleveland OH </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-right:42px; margin-left:96px; text-indent:-95px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">2:00 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Extending the eXpanded nystagmus acuity function to vertical and </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">multiplanar data </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Jonathan Jac</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">obs, Cleveland, OH </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-right:18px; margin-left:96px; text-indent:-95px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">2:15 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Inertial and non</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">inertial contributions to the perception of translation </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">and path </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Scott Seidman, Rochester, NY </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:54px; margin-left:96px; text-indent:-95px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">2:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">The effect of the Duncker visual illusion on smooth arm tracking </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Ari Zivotofsky, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Tel Aviv</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, Israel </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:105px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">2:45 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">PM </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Posterior internuclear ophthalmoplegia of Lutz revisited </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Bernd Remler, Milwaukee, WI </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-right:32px; margin-left:96px; text-indent:-95px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">3:00 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Divergence insufficiency in patients with hereditary spinocerebellar </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">ataxia </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Patrick Lavin, Nashville, TN </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:60px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">3:15 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Neuromuscular junction dysfunction in </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Miller Fisher Syndrome </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Janet Rucker, Chicago, IL </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-right:7px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">3:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Involuntary version</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">vergence nystagmus induced by ground plane optic </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">flow: analysis of dynamic characteristics of nystagmus quick phases </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Dongsheng Yang, Pittsburgh, PA </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:26px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">3:45 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Neuro</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">ophthalmol</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">ogical complications of chiropractic manipulation </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Michael Devereaux, Cleveland, OH </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-right:194px; margin-left:96px; text-indent:-95px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">4:00 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Vergence hysteresis in infantile nystagmus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Alessandro Serra, Sardinia, Italy </SPAN></P><P style="text-align:justify; margin-bottom:0px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">4:15 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Using wavelet analysis to evaluate effec</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">ts of eye and head movements on </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">ocular oscillations </SPAN></P><P style="text-align:justify; margin-bottom:19px; margin-left:96px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Ke Liao, Cleveland, OH </SPAN></P><P style="text-align:justify; margin-bottom:56px; margin-right:7px; margin-left:96px; text-indent:-95px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">4:30 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">P</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">M 	</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Contributions of electroretinograms to diagnosis in infantile nystagmus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Elisa Bala, Cleveland, OH </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">4:45 PM A Summing Up: Robert B. Daroff and Louis F. Dell’Osso </SPAN><SPAN style=" font-weight:normal"><SPAN style="font-size:12pt; color:#000000">Afferent and Efferen</SPAN><SPAN style="font-size:12pt; color:#000000">t Contributions to Knowledge of Eye Position </SPAN></SPAN></H4></DIV><DIV class="Sect"><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Ewa Niechwiej</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Szwedo &amp; Martin J. Steinbach </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Vision Science Research, University of Toronto and Toronto Western Hospital </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Toronto, Canada </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">To stay informed about the position of the eyes in the orbits, the brain ha</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">s available two </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">extraretinal signals: a copy of the efferent signal (outflow) to the extraocular muscles </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">(EOM) and proprioception (inflow) from the EOM. Palisade endings (PE), associated </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">with the multiply innervated fibers (MIF) of the global layer of EOM</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, are the putative </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">receptors supplying the inflow eye position signal. Buettner</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Ennever’s proprioceptive </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">hypothesis for the control of eye movements is based on neuroanatomical tracing studies </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">that identified a distinct set of non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">twitch (NT) motoneurons </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">whose activity does not add </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">to the force used to move the eyes. It has been suggested that NT motoneurons could be </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">involved in modulating the gain of sensory feedback from the eye muscles analogous to </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the gamma</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">efferent fibres that control the sensitivity </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of muscle spindles in skeletal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">muscles. We tested this in a series of studies where the activity of NT motoneurons was </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">altered using the Jendrassik Maneuver (JM). JM facilitates the amplitude of all tendon </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">reflexes, which is likely due to the general up</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">regulation of the gamma system. We </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">found that the JM perturbation altered registered vergence eye position when observers </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">localized targets in depth. Surprisingly, the JM did not affect higher order perceptual </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">judgments (size constancies), nor did it af</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">fect the saccadic system. Overall, our studies </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">provide insight into the putative mechanism involved in the control of sensory feedback </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">from the EOM. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Perceptual influences of extra</SPAN><SPAN style="font-size:12pt; color:#000000">-</SPAN><SPAN style="font-size:12pt; color:#000000">retinal signals for normal eye movements and </SPAN><SPAN style="font-size:12pt; color:#000000">infantile nystagmus. </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Harol</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">d E. Bedell</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1,2</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Jianliang Tong</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Saumil S. Patel</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>3 </Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">&amp; Janis M. White</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>4 1 </Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">College of Optometry, University of Houston, Houston TX 77204-2020 </SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>2 </Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Center for Neuro</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Engineering &amp; Cognitive Science, University of Houston, </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Houston TX 77204</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">4005 </SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>3 </Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Departments of Neur</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">obiology and Anatomy, University of Texas Medical </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">School, Houston, TX 77030</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>4 </Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">VA New Jersey Health Care System, East Orange, NJ 07018-1023 </SPAN></P><P style="text-align:left; margin-bottom:0px; text-indent:32px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">The involuntary eye movements in patients with infantile nystagmus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">(IN) generate rapid to</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">fro motion of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the retinal image, which has the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">potential to produce oscillopsia and the perception of motion smear. In </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">normal subjects, extra</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">retinal signals can neurally &quot;cancel&quot; the retinal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">image motion that occurs during eye movements and can reduce the extent of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">per</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ceived motion smear. Previous studies indicate that extra</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">retinal signals </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">contribute also to perceived stability in subjects with IN. In addition to </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">&quot;canceling&quot; the to</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">fro motion of the retinal image, extra</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">retinal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">signals also compensate partly for ch</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">anges in retinal</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">image orientation that </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">occur during the torsional component of IN. We show that extra</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">retinal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">signals reduce perceived motion smear in a subject with IN, preferentially </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">for relative target motion in the opposite direction of slow</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">phase eye </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">movements. A possible mechanism for the reduction of perceived motion smear </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">is a decrease in the duration of the temporal impulse response function </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">during eye movements. Temporal contrast sensitivities measured in normal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">observers and subjects with IN are </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">consistent with this possibility. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Although extra</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">retinal eye</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">movement signals have similar influences on </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">perceived stability and clarity in normal observers and subjects with IN, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the characteristics of the operative neural mechanisms may not be identical. </SPAN></P></DIV><DIV class="Sect"><H4 style="text-align:justify; margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Perception with unstable vision </SPAN></H4><P style="text-align:; margin-bottom:0px; margin-left:28px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Richard Abadi, Manchester University, UK </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px; margin-right:8px; line-height:18px"><SPAN style="font-size:12pt; color:#000000">Internal and external influences on foveation and perception in infantile nystagmus </SPAN><SPAN style="font-size:12pt; color:#000000">syndrome </SPAN></H4><P style="text-align:left; margin-bottom:19px; margin-right:37px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Larry A. Abel, PhD</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1 </Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">and Linda Malesic, PhD</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>2</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, </SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Department of Optome</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">try &amp; Vision </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Sciences, University of Melbourne and </SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>2</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Department of Clinical Vision Sciences, La </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Trobe University, Melbourne, Australia. </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Infantile nystagmus syndrome (INS) is a disorder which, more than many other </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">disturbances of vision, is influenced by a </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">range of both internal and external factors. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Manipulation of stimulus characteristics such as contrast have shown that this can </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">provoke oscillopsia</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">—</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">a perception of environmental motion often said to be absent in </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">INS. Rapidly flickering stimuli can also lea</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">d to multiply perceived images. Some internal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">factors, such as variability with gaze position, have been well documented. Others, such </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">as, exacerbation with visual effort, are widely described but have almost never been </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">formally studied. In one study which </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">examined this, the expected relationship was not </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">found, but subjects’ comments suggested that an absence of motivation may have been </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">contributory. Although case reports have shown stress or anxiety to exacerbate INS and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">provoke oscillopsia, systematic stu</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">dies have been lacking. Similarly, changes in visual </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">function or ocular alignment in adulthood may decrease foveation and elicit oscillopsia in </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nystagmus patients previously free of this symptom. Future models of INS should </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">incorporate modulatory inputs fr</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">om the limbic system which represent motivational or </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">stress</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">related influences as well as limits on the functioning of the mechanisms which </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">compensate for retinal image motion and thus suppress oscillopsia. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Perceptual Fading during Voluntary and Involun</SPAN><SPAN style="font-size:12pt; color:#000000">tary Eye Movements </SPAN></H4><P style="text-align:left; margin-bottom:37px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">F.A. </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Proudlock, A.Y. Jorgensen and I. Gottlob </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">University of Leicester, RBT Kilpatrick Clinical Science, Leicester Royal Infirmary, </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Leicester, LE27LX, United Kingdom </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Purpose: Perceptual fading (PF) is a phenomenon in which a target in t</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">he visual field </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">fades from view after a certain fading time (FT). PF is reset by microsaccadic eye </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">movements; however, PF has not been investigated during non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">fixation eye movements. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">We compared PF during voluntary eye movements in healthy volunteers and i</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">n patients </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">with involuntary eye oscillations caused by nystagmus. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Methods: Twelve healthy volunteers performed a PF task consisting of following an </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">oscillating fixation cross moving with either sine wave (pursuit task) or square wave </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">(saccadic task) profi</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">le while viewing a static peripheral spot of low contrast (1.5x </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">threshold). This was compared to FT during a static fixation cross with peripheral spot </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">moving and also when both were moving. FT was also compared in four volunteers with </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nystagmus. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Results: </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">During pursuit, FT was significantly longer for the static cross + moving target </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">condition compared to the moving cross + static target (p=0.04) and moving cross + </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">moving target (p=0.001). In contrast, during the saccadic trial, FT was similar for static </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">c</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ross + moving target, and, moving cross + static target tasks, but both were lower than </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the moving cross + moving target task. FT was more strongly correlated to retinal speed </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of the PF target during square wave than sine wave tasks. FT was correlated to f</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">oveation </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">in the four subjects with nystagmus. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Conclusions: We describe the PF during voluntary eye movements when stimuli are </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">applied at low contrast. Fading time was not simply related to retinal velocity of the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">target but also to efferent information. I</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nterestingly, patients with involuntary eye </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">movements could also fill</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">–</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">in targets although responses were more variable than healthy </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">volunteers. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Alternating Saccades in A Primate Model of Strabismus </SPAN></H4><P style="text-align:left; margin-bottom:37px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Vallabh E. Das</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1,<SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal">2 
</SPAN></Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Division of Sensory</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Motor Systems</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Ye</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">rkes National Primate Research Center</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, 
</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Department of Neurology</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>2</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Emory University, Atlanta, GA 30322</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">. 
</SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Alternating fixation is frequently observed in humans with strabismus. Here we examined </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">this phenomenon in a monkey model for strabismus. An exotropic s</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">trabismus was </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">induced in two infant monkeys using an alternate monocular occlusion paradigm for the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">first four months of life. When the animals were about three years old, we measured </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">binocular eye movements, using the scleral search coil technique, as the</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">y performed a </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">visually guided saccade task during monocular or binocular viewing. During binocular </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">viewing, monkeys tended to fixate targets in the right hemifield with their right eye and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">targets in the left hemifield with their left eye, mimicking patter</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ns of visual suppression </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">in exotropia. An alternating saccade was executed when the target jumped across the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">midline. There were no significant differences in the amplitude</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">peak velocity or </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">amplitude</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">duration main sequence relationships between alternating </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">alternating </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">saccades (monocular or binocular viewing). Saccade latency tended to be greater during </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">binocular viewing than during monocular viewing. Our study establishes a strabismus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">monkey model useful for studying neural circuits involved in gen</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">erating alternating </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">fixation and alternating saccade behavior. Further, alternating saccade behavior may be </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">used as a probe to study mechanisms of visual suppression. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Effects of cerebellar lesions in monkey on gaze stability </SPAN></H4><P style="text-align:left; margin-bottom:37px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Mark Walker, Johns Hopkins </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">University, Baltimore </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Studies in humans and animals have shown that the cerebellum plays a vital role in </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">calibrating eye movements to maintain gaze stability. Several cerebellar areas have been </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">found to be of particular importance. The oculomotor vermis</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, acting through the fastigial </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nuclei, controls the size of saccades. The flocculus and paraflocculus assist fixation and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">control eccentric gaze</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">holding; lesions here cause spontaneous (e.g., downbeat) and gaze</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">evoked nystagmus. They also are responsible t</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">o calibrating the gain of the rotational </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">(angular) vestibulo</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ocular reflex (VOR). </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Here we focus on the function of the cerebellar nodulus and uvula in stabilizing the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">foveal image when the object of regard is moving (smooth pursuit) and during linear </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">motio</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">n of the head (the translational VOR). Eye movements of two rhesus monkeys were </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">recorded using the magnetic field search coil method, before and after surgical ablation of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the nodulus and uvula. Key findings included: (1) there was an asymmetric deficit of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vertical smooth pursuit </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">– </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">downward, but not upward pursuit was impaired; (2) the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vertical translational VOR was reduced, for both upward and downward translation; and </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">(3) </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the sustained, but not the initial, response to abrupt horizontal translations was </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">i</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">mpaired. Our results, in combination with prior studies, support a role for the nodulus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and uvula in mediating vertical ocular following reflexes, in controlling the horizontal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">TVOR (possibly acting as an integrator of head acceleration), and in the determ</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ination of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">gravitational orientation. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px; margin-right:8px; line-height:18px"><SPAN style="font-size:12pt; color:#000000">Development of visual stabilization devices with potential applications to congenital </SPAN><SPAN style="font-size:12pt; color:#000000">nystagmus </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Igor Kofman and John Stahl</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Cleveland Ohio </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">The deleterious consequences of nystagmus include oscillopsia and reduced </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">acuity. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Although several medical and surgical interventions have been demonstrated to be </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">efficacious in specific patients/nystagmus types, the treatments are neither universally </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">effective nor always tolerable. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Optomechanical devices that stabilize vision </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">by nullifying </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the image motion produced by the nystagmus have the potential to improve vision in </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">treatment</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">resistant patients. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Such devices may also be used to predict the degree of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">benefit a patient may expect to receive from a contemplated medical or s</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">urgical therapy. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">A predictive tool would be particularly useful when the contemplated therapy involves </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">significant expenses, risks, or discomforts. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Visual stabilization devices can also be </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">applied as research tools to manipulate retinal image velocity an</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">d explore its effects on </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nystagmus waveform and oscillopsia. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Optomechanical stabilization systems consist of an </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">eye movement tracking device, a filtering system to extract the pathological movement </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">from the overall eye movement, and an optical or display </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">mechanism (the stabilizer plant) </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">that allows the seen world or displayed images to be oscillated synchronously with the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">patients nystagmus. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Our laboratory has worked to develop a practical, self</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">contained </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">visual stabilization device. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">In this chapter we r</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">eview our experiences with the device, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">emphasizing the development of the filter and stabilizer plant. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Although we focus on the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">treatment of acquired pendular nystagmus, we also present the effects of visual </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">stabilization in one patient with congenital ny</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">stagmus, as an illustration of how a </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">computer</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">controlled stabilizer might serve as a research tool. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px; margin-right:77px; line-height:18px"><SPAN style="font-size:12pt; color:#000000">Pupil abnormality of the near response in children with the “information </SPAN><SPAN style="font-size:12pt; color:#000000">technology” syndrome </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Akio Tabuchi, Atsushi Fujiwara, and Mahmoodi Kha</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">dija </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Department of Sensory Science, Kawasaki University of Medical Welfare, Kurashiki, </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Japan </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">“Information technology” syndrome or “Visual Display Terminals (VDT)” syndrome is </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the complex of eye and vision problems which associated with systemic disorders </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">related </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">to </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">near viewing, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">for long </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">periods, during </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">which </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">time individuals </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">are </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">exposed </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">to </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">electromagnetic (Computer, Television, cellular phone…) use. Nowadays, millions of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">children use VDT in school and at home for educations and recreation. Children can </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ex</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">perience many of the same symptoms related to VDT use as adults. In healthy eyes, the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">pupils naturally change size and position as focus shifts from far to near objects during </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">using VDT. In this study, we analyzed a pupil abnormality of the near response, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">that is </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">convergence, accommodation, and miosis, using by TriIRIS C9000 ( Hamamatsu </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Photonics, Hamamatsu, Japan) in a group of children aged from 13 to 15 years old. We </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">included </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">129 normal students</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">excluding those with </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">refractive error. All of them used </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">so</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">me kinds of VDTs (Personal computer, TV, TV</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Game, Mobile game, Phone). Among </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">129 students</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">101 (78.3%) had normal pupillary response and 28 students (21.7%) had </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">abnormal pupillary response. The pupil abnormality during using of VDT is thought to be </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">mediate</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">d by autonomic system disorders that controlled the pupil response during near </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">work. Continuously using of VDT </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">leads to </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">an abnormality in pupillary response. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px; margin-right:20px"><SPAN style="font-size:12pt; color:#000000">Genetics and pharmacological treatment of nystagmus: A review of the literature </SPAN><SPAN style="font-size:12pt; color:#000000">and recent n</SPAN><SPAN style="font-size:12pt; color:#000000">ew findings. </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Irene Gottlob</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, University of Leicester, U.K. </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">New developments in genetics and pharmacological treatment of nystagmus are </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">reviewed. While cases of nystagmus are frequently sporadic, kindreds in which </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nystagmus segregated as an autosomal domina</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nt, autosomal recessive, or X</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">linked trait </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">have been reported. Of these, X</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">linked pedigrees are the most frequent. By linkage </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">analysis, the major X</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">linked locus for nystagmus (NYS1) was localised to chromosome </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Xq26</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">q27. Linkage analysis and DNA sequence a</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nalysis performed in 26 families with </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">idiopathic congenital nystagmus (ICN) led to the detection of a novel gene named </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">FRMD7 (FERM domain containing 7) at Xq26.2 in which we have identified 22 different </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">mutations. Mutations in the FRMD7 gene encode a previ</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ously unidentified member of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the protein 4.1 superfamily. Several drugs have been used to treat acquired nystagmus, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">however pharmacological treatment has so far not been used in congenital nystagmus. A </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">randomised study showed that memantine (up to 40 mg) a</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nd gabapentin (up to 2400 mg) </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">can improve significantly visual acuity in CIN and reduce nystagmus in CIN and in </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nystagmus associated to ocular disease. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">New treatments for infantile and other forms of nystagmus </SPAN></H4><P style="text-align:left; margin-bottom:19px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Louis Dell’Osso</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Cleveland OH </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Objectives. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">To translate the past 40 years of infantile nystagmus syndrome (INS) research </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">(i.e., ocular motor recording and control</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">systems analysis) into a therapeutic approach. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Materials and Methods. Our eye</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">movement recordings use infrared reflection, magnetic </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">sear</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ch coil, and high</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">speed digital video systems. Each eye was calibrated during </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">monocular fixation (fellow eye occluded). We analyzed and displayed all data using </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">software developed and written in our laboratory in the MATLAB environment, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">including the eXpan</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ded Nystagmus Acuity Function (NAFX). Results. Analysis of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">~1000 INS subjects over 40 years revealed waveform characteristics that can be exploited </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">therapeutically. Analysis of post</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">operative INS data suggested that tenotomy and resuture </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">(at the original i</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nsertions) of the extraocular muscles in the plane of the IN would </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">improve foveation. The NAFX across normal gaze</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">angles showed both peak</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">value </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">increases and NAFX curve broadening. Conclusions. All patients with nystagmus should </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">have eye</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">movement recording </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and analysis. The resulting accurate diagnosis and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">documentation of INS characteristics (undetectable by clinical observation) will identify </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the best therapy. NAFX analysis allows estimation of post</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">operative acuities and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">determination of the most appropr</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">iate therapies. This eye</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">movement based procedure is </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the first to provide both the physician and patient with a post</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">therapeutic estimation of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">specific improvements in visual function not possible from acuity measurements alone. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Clinical and Electrophys</SPAN><SPAN style="font-size:12pt; color:#000000">iological Results of Eye Muscle Surgery in 53 Patients with </SPAN><SPAN style="font-size:12pt; color:#000000">Infantile Periodic Alternating Nystagmus (IPAN) </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Richard W. Hertle, Dongsheng Yang and Leah Reznick</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, University of Pittsburgh, PA </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Purpose </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Of 1,026 evaluations performed between the years 1998</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">20</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">06 in 506 patients </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">with INS, 78 had ocular oscillations consistent with IPAN. 53 had eye muscle surgery </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and are the subjects of this report. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Results </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Age was 1 to 67 yrs, 57% had pure periodicity, 43% aperiodicity, 42% had </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">albinism, 42% had strabismus, 4</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">0% had amblyopia and 32% had other eye disease. All </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">patients had all four horizontal recti operated. In 15% for strabismus alone, 36% for an </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">AHP alone, 13% for strabismus and an AHP and 36% had tenotomy alone. After surgery </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">static AHP and strabimus impr</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">oved, binocular LogMAR acuity increased from 0.55 to </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">0.42 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">(p &lt; .01), the periodic cycle average increased from 221 sec to 256 sec (p &lt; .01), the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">null period increased from 11.2 sec to 20 sec (p&lt;.001), best foveation increased from 132 </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">msec to 178 msec (p&lt;0</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">.05) and 43% changed to a more visually favorable waveform. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">There were no differences in cycle symmetry about the null period or the four surgical </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">indication groups. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Discussion </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">IPAN as part of INS is 15% in our population. Surgery on the eye muscles </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">these patients improves multiple ocular motor and visual system functions. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Surgical Treatments for Acquired Forms of Nystagmus </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Robert L. Tomsak, MD, PhD </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Professor of Neurology and Ophthalmology </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Case Western Reserve University School of Medicine </SPAN></P><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Three p</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">atients with acquired nystagmus were treated with eye muscle tenotomy. </SPAN></P><ol style="list-style-type:decimal"><LI><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">The first patient had acquired pendular nystagmus (APN) from MS and underwent </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">bilateral medial rectus tenotomies and bilateral lateral rectus recessions to also correct </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">exotropia. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Eye movements were recorded by the scleral search coil technique at three </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">times: before surgery, after surgery, and after surgery and treatment with memantine. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Following surgery, APN decreased by ~50% and the expanded nystagmus acuity function </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">(NAFX) incr</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">eased by 34%. Measured Snellen acuity increased 100% from 0.125 OD and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">OS to 0.25. Saccades were unaffected. After treatment with memantine, APN was </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">damped further by 69% and NAFX was improved an additional 9%; Snellen acuity </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">increased 60% to 0.4. </SPAN></LI><LI><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">The </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">second patient had unilateral APN caused by MS. Pre</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and post</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">tenotomy eye </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">movements were studied using digitized video recordings. The horizontal recti were </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">tenotomized and reattached in only the APN eye. This resulted in damping of the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nystagmus by 66%, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and Snellen acuity increased 100% from 0.2 to 0.4. </SPAN></LI><LI><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">The third patient had downbeat nystagmus (DBN) of undetermined etiology, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">oscillopsia, and vertical diplopia from skew deviation; he preferred a chin</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">down (upgaze) </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">head position to diminish symptoms. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Pre</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and post</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">tenotomy eye movements were </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">recorded by a high</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">speed digital video system. Asymmetric superior rectus recessions </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">were done to address head position and hypertropia and were combined with tenotomy </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and reattachment of both inferior recti. Surge</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ry resulted in movement of the NAFX peak </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">from 10 deg up to primary position, and NAFX values were improved by 17%. Vertical </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">NAFX values increased across the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">–</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">10 deg to +5 deg vertical range. Foveation time per </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">cycle increased from 88 ms to 178 ms (102%). </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Vertical component amplitude was </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">reduced by 46% and frequency was unchanged at ~3 Hz. Visual acuity was improved </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">from 20/25 to 20/20, and the hypertropia was improved. </SPAN></LI></ol><P style="text-align:left; margin-bottom:0px; margin-right:55px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Conclusions: Eye muscle tenotomy appears to have salutary effects on acquired </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nystagmus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of differing etiologies and different neuroanatomic sites of origin; this </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">supports its hypothesized proprioceptive mechanism of action. The addition of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">memantine in one patient with APN augmented the effects of tenotomy. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px; margin-right:37px"><SPAN style="font-size:12pt; color:#000000">Effect of Eye Exercise on Clinica</SPAN><SPAN style="font-size:12pt; color:#000000">l Outcome of Non</SPAN><SPAN style="font-size:12pt; color:#000000">-</SPAN><SPAN style="font-size:12pt; color:#000000">Compressive Ocular Motor </SPAN><SPAN style="font-size:12pt; color:#000000">Nerve Palsy </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">A. </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Poonyathalang,</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1 </Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">P. Preechawat</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1 1</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Department of Ophthalmology, Ramathibodi Hospital, Mahidol University, Bangkok, </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Thailand </SPAN></P><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Objective</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">: </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">To study the effect of eye exercise on non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">compressive ocular mot</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">or nerve </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">palsy treatment in addition to medical treatment. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Background</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">: </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Treatment of ocular motor nerve palsy by occlusion, prism and botulinum </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">toxin injection are used to reduce diplopia symptoms. To reduce recovery time, the use of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">eye movement exercises </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">has been introduced. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Method</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">: </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Patients with ocular motor nerve palsy were randomly instructed to move their </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">eyes back and forth in directions of paresis 100 times a day. Time from onset to normal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">fusion was recorded and compared between an exercise and non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">exercise group. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Results</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">: </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Eleven patients had cranial third nerve palsy, twelve had sixth nerve palsy and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">one had both third and sixth nerve palsy. All patients were </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">treated with oral a</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">spirin or </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">other anti</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">platelet </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">therapy</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">. The eye exercise group included n</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ine patients and non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">eye </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">exercise group had fifteen patients. The eye exercise group had an average recovery time </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of 3.8 weeks as compared to the 25.5 weeks for the non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">exercise group. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Conclusion</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">: </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Patients who performed eye exercises had shorter recovery </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">times from </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">double vision than patients who were only given medical treatment. However, since our </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">sample size was very small, other parameters could possibly be responsible for the results </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">that were seen. </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">References </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">1. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Everhard</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Halm YS, Koornneef L, Zonne</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">veld FW. Conservative therapy frequently </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">indicated in blow out fractures of the orbit. Ned Tijdschr Geneeskd. 1991; 135(27):1226</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000"></SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">8. </SPAN></P><P style="text-align:left; margin-bottom:0px; margin-right:12px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">2. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Kawahira K, Shimodozono M, Etoh S, Tanaka N. New facilitation exercise using the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vestibulo</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ocular reflex for ophthalmopl</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">egia: preliminary report. Clin Rehabil. 2005; </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">19(6):627</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">34. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px; margin-right:12px"><SPAN style="font-size:12pt; color:#000000">Expanding the Original Behavioral Infantile Nystagmus Syndrome Model to Jerk </SPAN><SPAN style="font-size:12pt; color:#000000">Waveforms and Gaze</SPAN><SPAN style="font-size:12pt; color:#000000">-</SPAN><SPAN style="font-size:12pt; color:#000000">angle Variations </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Z.I. </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Wang, </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">L.F. Dell’Osso </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, and J.B. Jacobs</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Cleveland, OH </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Objectives. To expa</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nd the behavioral Ocular Motor System (OMS) model for Infantile </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Nystagmus Syndrome (INS) by: 1) incorporating jerk and jerk with extended foveation </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">waveforms with a unifying mechanism for both pendular and jerk waveforms; 2) </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">incorporating idiosyncratic var</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">iation of IN amplitude with gaze angles. Materials and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Methods. Ocular motor recordings of humans, using infrared reflection, high</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">speed </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">digital video, and magnetic search coil systems, were used as templates for the computer </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">simulations. All simulations a</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nd analyses were performed in MATLAB Simulink </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">environment. Results. Examinations of eye</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">movement data during different states of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">attention suggested that pendular and jerk INS waveforms came from the same </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">underlying smooth</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">pursuit</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">system oscillation. Simul</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ation of unidirectional jerk </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">waveforms, required a resettable neural integrator in the pursuit pre</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">motor circuitry. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Alexander’s law relationships were used to produce desired INS “null” positions and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">sharpness. At various gaze angles, these Alexander’s law </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">relationships influenced the IN </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">slow</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">phase amplitudes differently, thus mimicking the same gaze</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">angle effects observed </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">in INS patients. Conclusions. The simulations of a robust behavioral OMS model </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">demonstrated that both pendular and jerk waveforms can be </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">generated by the same </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">pursuit</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">system instability. Alexander’s law output effectively modulates the nystagmus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">variation at different gaze angles. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Extension of the eXpanded Nystagmus Acuity Function to Vertical and Multiplanar </SPAN><SPAN style="font-size:12pt; color:#000000">Data </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Jonathan B. Jacobs and </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Louis F. Dell’Osso</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Cleveland, OH </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Objectives. To update and extend the functionality of the eXpanded Nystagmus Acuity </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Function (NAFX), allowing for its application to biplanar nystagmus and improving its </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">predictive value in clinical evaluations. Materials </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and Methods. The original NAFX was </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">based on foveation times taken from a “tau surface,” an array whose values were </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">calculated for each combination of position and velocity limits of a “foveation window.” </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">For the updated NAFX, we replaced the empirical sur</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">face with a mathematically defined </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">surface that matched the original, but without the idiosynchratic irregularities due to the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">waveforms of the subjects used for its calculation. For biplanar data, we have </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">investigated combining horizontal and vertical eye</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">movement data into a single radial </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vector. Age</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">related relationships were incorporated for more accurate individual visual </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">acuities. Results. Using the same uniplanar patient data, we verified that the updated </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">NAFX yielded equivalent results as the origin</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">al NAFX for the foveation window limits </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">we tested. For biplanar data, the NAFX values were also comparable to those from </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">uniplanar data of the same magnitude. Conclusions. The new version of the NAFX </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">allows greater accuracy in predicting visual acuity for </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">subjects of all ages, for both </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">uniplanar and biplanar nystagmus. This will allow researchers and clinicians to select the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">best therapies for a wider range of nystagmus patients. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Inertial and non</SPAN><SPAN style="font-size:12pt; color:#000000">-</SPAN><SPAN style="font-size:12pt; color:#000000">inertial contributions to the perception of translation a</SPAN><SPAN style="font-size:12pt; color:#000000">nd path </SPAN></H4><P style="text-align:left; margin-bottom:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Scott </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">H. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Seidman</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">, University of Rochester, NY </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">The ability to determine the path of travel, or &quot;path integration&quot;, has </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">been reported to be robust in humans, and has been attributed to an </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">accurate double integration of acceleration signals transduce</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">d by the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">otolith organs to yield path information. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Vestibuloocular responses to </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">translational motion, however, are most robust at high frequencies of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">motion, and become somewhat feeble at frequencies typically used in the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">study of path integration; this o</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">bservation puts the otolith origin of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">path integration phenomena in doubt. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">To determine if path integration </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">behaviors might be mediated by cues of motion of a non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">inertial nature, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">such as vibration and noise that might accompany translational motion, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">we m</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">easured the perception of motion on two different apparatus: </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">one </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">that minimized non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">inertial cues of motion, and a second that </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">dissociated non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">inertial cues from actual motion. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">When non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">inertial cues are minimized, we observe a variety of high</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">pass </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">phen</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">omena in the perception of translation, including a decay in </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">magnitude during constant velocity travel, and decreasing magnitude </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">accompanied by increasing phase leads as the frequency of sinusoidal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">translation decreases. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">When cues are dissociated from mot</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ion, the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">perception of translation is heavily influenced by the non</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">inertial </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">cues. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">We conclude that otolith mechanisms are not sufficient to drive </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">path integration behaviors. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">The Effect of the Duncker Visual Illusion on Occluded Smooth Arm Tracking </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Ari </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Z. Zivotofsky</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Adi Bercovich</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1,3</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Jason Friedman</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>2</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Eva Kelman</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Elinor Shinhertz</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>1</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, and Tamar Flash</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>2 1</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">The Gonda Multidisciplinary Brain Research Center, Bar Ilan University, Ramat Gan, </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Israel </SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>2</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Department of Computer Science and Applied Mathematics, Weizman</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">n Institute of </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Science, Rehovot, Israel</SPAN><SPAN style="font-size:7.9pt; font-style:italic; font-weight:normal; color:#000000"><Sup>3</Sup></SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Department of Neurobiochemistry, Tel Aviv University, Tel Aviv, Israel </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Motor systems are required to perform coordinate transformations in order to accurately </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">translate the visual information utilized in the execut</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ion of the desired task. These </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">transformations can be affected by the presence of a visual illusion. The Duncker </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Illusion, also known as induced motion, is an illusion of motion that occurs in the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">presence of background movement. Previous studies have show</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">n that certain aspects of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the ocular motor system are influenced by this illusion in the same manner as the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">perceptual system is influenced. The present study examined the effect of the Duncker </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Illusion on hand tracking movements. Eight subjects were requi</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">red to track with their </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">hand using arm movements the trajectory of a smoothly moving target without the benefit </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of visual feedback. Our results show that in a significant number of trials with the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">illusion, the hand</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">tracking trajectory differed significant</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ly from its control condition in </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the direction opposite that of the illusion. This is explainable by positing that there were </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ocular following type eye movements generated by the flow</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">field movement that in turn </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">influenced the arm tracking. This presents a</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nother instance of a motor system whose </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">control system is impervious to influence by a visual illusion. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Posterior INO of Lutz revisited </SPAN></H4><P style="text-align:left; margin-bottom:19px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Bernd F. Remler and R. John Leigh </SPAN></P><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">In 1923 Anton Lutz proposed the existence of a posterior INO, i.e. a prenuclear pa</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">lsy of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the lateral rectus, analogous to the medial rectus palsy of “anterior INO”. His </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">innervational model postulated direct supranuclear projections to the 3rd nerve nucleus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">with collaterals to the 6th nerve nucleus. Despite the faulty anatomical concept </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">“Posterior </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">INO of Lutz” has persisted as a label for prenuclear abduction deficits. </SPAN></P><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">This case report regards a 50yo man who presented with insidious onset diplopia on </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">rightward gaze. His examination demonstrated a minimal abduction deficit and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">esodeviat</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ion OD, which increased on rightward gaze. After initially negative imaging, a </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">small midbrain lesion evolved in the supranuclear region of the R 3rd nerve nucleus. The </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">lesion and ocular motor findings have remained nearly unchanged over &gt;2 years. An eye </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">mo</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vement recording confirmed the abduction deficit, but saccadic velocities were in the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">normal range. Vertical gaze was intact. </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">“Posterior INO of Lutz” has been attributed to a disconnection between the PPRF and the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">abducens nucleus. Midbrain lesions are al</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">so associated with abduction deficits suggesting </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">that internuclear connections between the 3rd and 6th nerve nuclei may exist. However, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">other anatomical concepts could account for our patient’s findings including loss of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">supranuclear medial rectus inhibiti</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">on. A functional and anatomical classification should </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">replace the diagnosis of “Posterior INO of Lutz” because variable anatomical locations </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">are associated with prenuclear abduction deficits. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Divergence insufficiency in patients with hereditary spinocereb</SPAN><SPAN style="font-size:12pt; color:#000000">ellar ataxia </SPAN></H4><P style="text-align:left; margin-bottom:19px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Patrick Lavin, Nashville, TN </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Divergence insufficiency is characterized by five criteria: 1) acquired uncrossed </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">horizontal diplopia at distance, but not near; 2) comitant esotropia at distance; 3) full </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ductions; 4) normal abducting saccades, w</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ith no signs of abducens palsies; 5) reduced or </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">absent fusional divergence. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Unfortunately, the terms divergence insufficiency (DI) and divergence paralysis (DP) are </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">used interchangeably. Bruce (1935) distinguished between “divergence insufficiency” in </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">whi</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ch an otherwise healthy patient develops sudden onset esotropia at distance, and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">“divergence paralysis” which is associated with underlying neurological diseases. DI can </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">be distinguished from divergence paralysis which occurs as a result of bilateral abdu</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">cens </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">palsies in patients with severe head injuries, intracranial hypertension, intracranial </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">hypotension, brainstem tumors, craniocervical junction abnormalities, and Fisher’s </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">syndrome. Patients usually have bilateral abduction deficits, horizontal diplopi</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">a at </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">distance, and quantitatively slowed abducting saccades. DI can be difficult to distinguish </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">from DP in those recovering who go through a phase during which the esotropia becomes </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">comitant with full ductions, mimicking DI; however, quantitative abductin</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">g saccades are </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">generally slowed. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">DI generally occurs in patients who otherwise appear neurologically normal; </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">occasionally, it occurs with Chiari I malformations, midline cerebellar degeneration and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">sedation (diazepam). The association of DI and hereditary </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">spinocerebellar degeneration </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">is not well known; the purpose of this study is to report the association of DI with </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">hereditary spinocerebellar ataxia in six patients and discuss their management. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Neuromuscular Junction Dysfunction In Miller Fisher Syndrome </SPAN></H4><P style="text-align:left; margin-bottom:19px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Janet Rucker, Chicago, IL </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Introduction: Miller Fisher syndrome (MFS) consists of a triad including </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ophthalmoplegia, ataxia, and areflexia with a self</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">limited monophasic course. Anti</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">GQ1b </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">antibodies are present in up to 90% of patients. It is considere</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">d a variant of Guillain</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Barre, with the primary pathology considered to be peripheral nerve demyelination. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Methods: A 43 year old man with an acetylcholine receptor antibody</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">negative diagnosis </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of myasthenia gravis for a 3 month monophasic illness 15 year</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">s prior presented with </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">binocular diplopia. Electrophysiologic studies prior to neuro</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ophthalmologic evaluation </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">revealed a decremental response to repetitive stimulation. Relapse of myasthenia gravis </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">was the working diagnosis. Neuro</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ophthalmologic examin</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ation and literature review </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">were performed. Results: Examination revealed diffuse bilateral ophthalmoplegia, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">bilateral pupillary light</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">near dissociation, and areflexia. Cerebellar function was normal. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Cerebrospinal fluid was normal. Anti</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">GQ1b antibodi</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">es were positive. Recurrent MFS </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">was diagnosed. Primary neuromuscular junction pathology in MFS is reported </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">electrophysiologically and pathologically in a mouse diaphragm / phrenic nerve model </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">upon exposure to human GQ1b antibodies. Three human cases of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">GQ1b positive MFS </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">with abnormal single fiber EMG and two with incremental responses to repetitive </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">stimulation are described. Conclusion: The patient in this case report brings to light a </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">developing recognition in the human clinical literature of neuromus</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">cular dysfunction in </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">MFS, which is well</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">founded in basic science studies. Systematic evaluation of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">neuromuscular junction physiology should be performed in MFS patients to advance </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">understanding of this process. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px; margin-right:45px; line-height:18px"><SPAN style="font-size:12pt; color:#000000">Involuntary version</SPAN><SPAN style="font-size:12pt; color:#000000">-</SPAN><SPAN style="font-size:12pt; color:#000000">vergence nystagmus i</SPAN><SPAN style="font-size:12pt; color:#000000">nduced by ground plane optic flow: </SPAN><SPAN style="font-size:12pt; color:#000000">analysis of dynamic characteristics of nystagmus quick phases </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Dongsheng Yang Ph.D., Mingxia Zhu Ph.D. and Richard W. Hertle M.D. </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">The Laboratory of Visual and Ocular Motor Physiology, The Children’s Hospital of </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Pittsburgh </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">and The UPMC Eye Center, Department of Ophthalmology, The University of </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Pittsburgh Pittsburgh, PA 15213 </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">We used a new ground plane motion stimuli displayed on a computer monitor in the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ground plane to induce involuntary version</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vergence nystagmus. Eye mo</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vements were </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">recorded with a search coil system. The involuntary version</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vergence nystagmus had </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">both vertical version and horizontal vergence components. Quick phases of both </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vergence and version components were analyzed. Backward motion induced monophasi</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">c </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">divergent quick phases and upward versional quick phases. Forward motion induced </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">biphasic divergence</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">convergence quick phases and downward versional quick phases. A </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">time dissociation of about 20 ms between version velocity peak and convergence velocity </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">p</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">eak was observed. Vergence peak time had a dependence on version peak time. Linear </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">relationships between vergence peak velocity and versional saccadic peak velocity were </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">demonstrated under binocular viewing conditions, but not monocular viewing conditions. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Our data support the hypothesis that the vergence system and the saccadic system can act </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">separately, but interact with each other whenever they occur simultaneously. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Keywords: nystagmus, vergence, eye movements, optic flow </SPAN></P></DIV><DIV class="Sect"><H4 style="text-align:justify; margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">The Neuro</SPAN><SPAN style="font-size:12pt; color:#000000">-</SPAN><SPAN style="font-size:12pt; color:#000000">Ophthalmologic C</SPAN><SPAN style="font-size:12pt; color:#000000">omplications of Cervical Manipulation </SPAN></H4><P style="text-align:justify; margin-bottom:19px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Michael Devereaux, Cleveland OH </SPAN></P><P style="text-align:justify; margin-bottom:0px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Cervical manipulation, specifically chiropractic manipulation, is an important cause of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vertebral basilar and rarely carotid artery distribution strokes. The mechanism of action </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of vert</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ebral artery distribution strokes is vertebral artery dissection at the level of the atlas </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">as a result of rotation and extension of the head, which can occur in association with </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">chiropractic manipulation. The vertebral arteries are tethered as they pass th</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">rough the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">dura. Rotation of the atlas around the axis can lead to stretching of the vertebral artery on </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the side opposite the direction of head rotation, with a resultant intimal tear, and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ultimately occlusion with thrombus formation and embolization. Neu</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ro</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ophthalmologic </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">findings are a common and at times relatively isolated feature of strokes secondary to </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">chiropractic manipulation. This is a more frequent occurrence than commonly </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">recognized. A variety of neuro</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ophthalmologic disturbances have been recogn</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ized </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">including visual field defects due to posterior cerebral artery distribution embolic strokes </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and oculomotor disturbances due to strokes anywhere in the brain stem, but most </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">commonly in the medulla. Strokes induced by therapeutic manipulation of the ne</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ck are </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">not rare. Patients, particularly young patients with significant stroke risk factors </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">presenting with vertebrobasilar strokes should be questioned as to whether they have </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">undergone cervical manipulation. Patients should be routinely instructed to avo</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">id </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">chiropractic neck manipulation. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px"><SPAN style="font-size:12pt; color:#000000">Vergence hysteresis in infantile nystagmus </SPAN></H4><P style="text-align:left; margin-bottom:19px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Alessandro Serra, </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">L. F. Dell’Osso, and Z.I. Wang </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Sardinia, Italy </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Objectives. To investigate the previously observed hysteresis (higher eXpanded </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Nystagmus Acuity Function (N</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">AFX) during divergence than convergence) effects of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">multi</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">and single</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">step vergence on visual acuity in a subject with Infantile Nystagmus </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Syndrome (INS). Materials and Methods. Eye movements were measured using a high</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">speed digital video system during fix</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ation of targets at 0º, stepping in from far to near </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">(60D) and back out (5 or 20 sec/fixation) as well as during single steps (1</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">5 seconds per </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">fixation). Results. Higher values of NAFX were achieved at far if the previous near target </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">was fixated for 5 seco</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">nds. Single steps between near and far (1 and 3 sec/fixation), did </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">not improve the following far NAFX. Double near shifts (F</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">N</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">F</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">N</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">F), yielded some </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">improvement in far NAFX values in one of two trials with 3</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">second fixations. Hysteresis </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">was still present fo</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">r 5</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">second fixations of multiple</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">step targets, whereas the NAFX </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">values were high at almost all near targets for 20</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">second fixations; hysteresis was </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">observed only at far. Conclusions. For better visual acuity at far, a fixat</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ion of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">≥</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">5 seconds </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of a near target is required. The time</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">dependent improvement of visual acuity during </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">convergence or divergence may reflect the time required by the pulleys to reduce the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">plant’s responsiveness allowing better vision. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px; margin-right:8px; line-height:18px"><SPAN style="font-size:12pt; color:#000000">Using Wavelet Anal</SPAN><SPAN style="font-size:12pt; color:#000000">ysis to Evaluate Effects of Eye and Head Movements on </SPAN><SPAN style="font-size:12pt; color:#000000">Ocular </SPAN><SPAN style="font-size:12pt; color:#000000">Oscillations </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">K. </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Liao1, S. Hong2, D. S. Zee3, L.M. Optican2, R. J. Leigh1 </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">1Case Western Reserve University, 2LSR/National Eye Institute, 3Johns Hopkins </SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">University. </SPAN></P><P style="text-align:left; margin-bottom:0px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Insights into the pathogenesis </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of certain ocular oscillations are provided by determining </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">whether eye or head movements can perturb or </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">“reset” the nystagmus. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">When the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">oscillations are regular and sinusoidal, this poses few problems, since the oscillations </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">prior to the perturbation can </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">be compared with those following. However, when the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ocular oscillations have an inherent randomness to them, such as the ocular oscillations of </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">oculopalatal tremor (OPT), such comparisons often will not determine whether the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">perturbation has phase</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">shifted </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the nystagmus. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">We applied complex wavelet analysis to </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">data from two patients with OPT and checked whether vestibular stimuli induced a </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">change in nystagmus amplitude or phase. The nystagmus signal was only present in </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">levels 6</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">8 (about 1</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">3 Hz) of the wavelet </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">decomposition. Statistical analysis indicated that, </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">within these levels, there was no change in the energy before or after head rotations. For </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">each head perturbation, we selected two nystagmus cycles prior to a head rotation and </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">shifted them by two peaks </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">to predict what the nystagmus would have been without the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">perturbation. We compared the prediction with the two cycles that followed the rotation. </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">The phase difference between the cycles before and after head rotation was determined </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">by wavelet coherence an</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">alysis. Because OPT is an aperiodic signal, small phase shifts </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">between any sets of two nystagmus cycles are expected, but the rate of change of phase </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">shift is low (&lt; 1000 deg/s). However, at the time of the head perturbation rate of change </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">of phase was lar</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ge (&gt; 2000 deg/s). We found that head perturbations caused significant (p </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">&lt; 0.05) rates of change of phase shift in both patients, confirming our </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">hypothesis that </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">the </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">mechanisms generating OPT receives </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">vestibular </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">inputs</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">. </SPAN></P></DIV><DIV class="Sect"><H4 style="margin-bottom:0px; margin-right:20px"><SPAN style="font-size:12pt; color:#000000">Multifocal Electroretinographic St</SPAN><SPAN style="font-size:12pt; color:#000000">udy of Patients with Oculocutaneous Albinism </SPAN><SPAN style="font-size:12pt; color:#000000">and Infantile Nystagmus Syndrome </SPAN></H4><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">Elisa Bala, Jonathan B. Jacobs, Neal S. Peachey</SPAN><SPAN style="font-size:12pt; font-style:italic; font-weight:normal; color:#000000">, Cleveland OH </SPAN></P><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Purpose: Some patients with infantile nystagmus syndrome (INS) have an afferent defect </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">that may be the limiting fac</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">tor for visual acuity. We used the multifocal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">electroretinogram (mfERG) to quantify retinal function in INS patients with </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">oculocutaneous albinism. </SPAN></P><P style="text-align:left; margin-bottom:19px; margin-right:31px; line-height:19px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Methods: We recorded mfERGs from two patients, using a standard stimulus (scaled </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">array with 103 hexagons cov</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">ering the central 45°). Recordings were made under </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">continuous fundus monitoring, allowing us to re</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">record segments with insufficient </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">fixation. Quantification of nystagmus waveforms was made using the eXpanded </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Nystagmus Acuity Function (NAFX). </SPAN></P><P style="text-align:left; margin-bottom:19px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Results: Use</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">able data were obtained from 3 of 4 eyes. One eye could not be recorded due </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">to large</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">-</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">amplitude nystagmus. In the usable recordings, analysis with concentric ring </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">averages showed reduced response amplitude only in the central areas, with normal </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">response amp</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">litudes peripherally. Implicit times were normal at all locations. </SPAN></P><P style="text-align:left; margin-bottom:0px; margin-right:12px; line-height:18px"><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">Conclusions: Our results are consistent with anatomical studies indicating that albino </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">retinas do not develop a central area of high cone density, and suggest that the potential </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">for good c</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">entral vision is limited in these patients, in agreement with a recent pediatric </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">study (Kelly &amp; Weiss, AJO 2006;141:1156). We determined that, for one patient, this </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">underdevelopment</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">–</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">rather than the nystagmus</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">–</SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">was the limiting factor, and she was less </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">likely </SPAN><SPAN style="font-family:'serif', 'Times New Roman PSMT'; font-size:12pt; font-weight:normal; color:#000000">to receive enough increase in visual acuity to warrant surgery. </SPAN></P></DIV></DIV></DIV></BODY></HTML>